As shown in the results of the current cohort, some subtypes of TILs present in the residual tumor such as CD3, CD8, and CD4, as well as CD4/FOXP3 and CD8/FOXP3 ratios, influenced survival outcomes. The gene discussed is FOXP3; the disease is neoplasm.